Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)

NCT03463733 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastoma

Interventions

DRUG: Hydroxyurea
DRUG: Temozolomide

Sponsor

M.E. van Linde

Collaborators

[object Object]